22nd Century Group, Inc. (NYSE MKT: XXII), a leader in tobacco harm reduction, recently announced that its wholly-owned subsidiary, Goodrich Tobacco Company, received a purchase order for 4.95 million SPECTRUM U.S. government research cigarettes.
22nd Century Group, Inc. (NYSE MKT: XXII) is currently trading $0.92 up 0..176 (1.96%) on the day with low volume. The 52 week range is from $0.52 to $3.12. The stock is currently short 4.01% or about 1.9 million shares of the float. The 22nd Century Group, Inc. (NYSE MKT: XXII) has a price target of $9.00 per share. The company has a current rating of outperform and quarterly revenue are up 1,4216%.
22nd Century Group, Inc. (NYSE MKT: XXII)
22nd Century Group, Inc., a plant biotechnology company, focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding.
It develops smoking cessation products and modified risk tobacco products for smokers who are unable or unwilling to quit smoking and who may be interested in cigarettes which reduce exposure to certain tobacco smoke toxins and/or pose a lower health risk than conventional cigarettes. The companys products include RED SUN and MAGIC regular and menthol cigarettes; and SPECTRUM government research cigarettes.
It is also developing X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy; and modified risk cigarettes, such as BRAND A, which has approximately 95% less nicotine than tobacco in cigarettes, as well as BRAND B cigarettes that contains low amount of tar per milligram of nicotine. The company was founded in 1998 and is based in Clarence, New York.
Learn more about 22nd Century Group, Inc. (NYSE MKT: XXII) www.xxiicentury.com